GlaxoSmithKline and Sanofi sharing 'innovative technology' to develop COVID-19 vaccine
April 14, 2020 at 09:09 AM EDT
The Big Pharma companies expect to begin clinical trials for their adjuvanted vaccine candidate during the second half of 2020.